Genetic Testing Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2015-2020 and Forecast 2021-2027

$ PRICE - $ 3,000.00$ 8,900.00

Global Genetic Testing Market: By Test Type (New-born Screening, Diagnostic Testing, Prenatal Testing, Carrier Testing, Predictive and Pre-Symptomatic Testing), By Technology (Molecular Testing, Cytogenetic Testing, Biochemical Testing), By Application (Thalassemia, Sickle Cell Anemia, Cancer, Cystic Fibrosis, Alzheimer’s Disease, Huntington’s Disease, Others), By End User (Hospitals, Clinics, Diagnostic Centers), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

Global Genetic Testing Market was valued at USD 13.6 Billion in 2020 and is anticipated to grow at USD 29.88 Billion till 2027 recording a CAGR of 11.9% during the forecast period 2021-2027. The DNA, a chemical databank that conveys commands for the body’s utilities, is examined during genetic testing. Changes or mutations in the genes that may cause illness or disease can be discovered by genetic testing. The rise in the incidence of genetic diseases and the growing demand for identifying genetic disorders are two major factors driving growth in the global genetic testing market. Chronic diseases are primarily caused by genetic abnormalities. Genetic testing makes available technology that aid in the early discovery of various genetic illnesses, as well as treatment and prevention. Genetic testing is widely utilised for a variety of applications. In 2015, there were around 15.1 million new cancer cases worldwide, with more than half of these instances coming from economically developing countries such as India, China, and others. Prenatal genetic testing is a procedure that aids in the detection of genetic diseases in the foetus. Mutations in a person’s genes or chromosomes are the most common cause of genetic disorders. Aneuploidy, trisomy, monosomy, and a variety of other hereditary illnesses are among the most common genetic abnormalities. Pharmacogenomics is the study of congenital changes in human genes that influence a person’s pharmacological response. Pharmacogenomics is a field that combines pharmaceutical and genetic sciences. As a result, it is the science of customising a medicine depending on a person’s genetic composition. A predisposition is an increase in the likelihood of a disease developing as a result of a person’s genetic composition. A genetic predisposition is caused by specific genetic abnormalities that are passed down from one parent to the next. Global genetic testing market report gives comprehensive outlook on genetic testing across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.


Genetic Testing Market

MARKET SUMMARY
-
11.9%
  • Study Period– 2021-2027
  • Base Year– 2020
  • CAGR–11.9%
  • Largest Market– North America
  • Fastest Growing Market– Europe

Genetic Testing Market

  •  The report on global genetic testing market gives historical, current, and future market sizes (US$ Bn) on the basis of test type, technology, application, end user, and region.
  • This report studies global market dynamics elaborately to indentify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition.
  • Moreover, PBI analyzed global market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).
  • Key stakeholders of the global genetic testing market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global genetic testing products
Market Key Players
  • Qiagen N.V.
  • PerkinElmer, Inc.
  • Applied Biosystems
  • Biocartis S.A.
  • Genentech, Inc.
  • Hoffmann La Roche Ltd.
  • Quest Diagnostics
  • Illumina, Inc.
  • Bayer Diagnostics
  • Konica Minolta, Inc.
  • Abbott Laboratories
  • Myriad Genetics
Growth

Genetic Testing Market

Technological advancements in the genetic testing enhances the revenue of genetic testing market over the forecast years. Advanced genetic testing technology enhances the precision of analysis of clinical biomarkers. Moreover, innovations in the genetic tests offer efficient and safer technique in the disease detection that may reduce the miscarriage during the early stage of pregnancy. Furthermore, surge in adoption of genetic testing among the population, favorable reimbursement policies, and presence of skilled professionals are bolster the genetic testing market over the forecast timeframe. Moreover, rise in adoption for the personalized medicine, increase in demand for early stage disease diagnosis, surge in adoption of genetic testing in developed and developing countries, and sophisticated healthcare infrastructure are the major factors that are driving the growth of the genetic testing market.


North-America Got Significant Share

Genetic Testing Market

North America accounted for larger revenue share in global market with significant CAGR. Increase in prevalence of genetic disorders such as cancer, diabetes, and other chronic diseases, rise in demand for personalized medicine, and grow in R&D for the development of advanced tests by the market players are propel the genetic testing market in the North America region. Europe market projected to grow at significant rate owing to increase in adoption of advanced genetic tests, rise in health awareness among the population, increase in the incidence of genetic disorders are expected to enhance the market.

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Key Findings of the Report

  • Global genetic testing market expanding at significant CAGR over 2021 to 2027 owing to launch of newer tests into market.
  • Based on application, cancer segment accounted for larger market revenue share in 2020 and projected gain market revenue share over the forecast period
  • Players focusing on innovation of newer products and collaboration strategies to retain market position in global genetic testing market

Key

Key Features of the Report

Genetic Testing Market Segmentation


Location

GEOGRAPHY


Report

Table Of Content

 

  1. Executive Summary
  2. Global Genetic Testing Market Introduction
    • Global Genetic Testing Market – Taxonomy
    • Global Genetic Testing Market –Definitions
      • Test Type
      • Technology
      • Application
  1. Global Genetic Testing Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Genetic Testing Market Dynamic Factors – Impact Analysis
    • Global Genetic Testing Market – Competition Landscape
  2. Global Genetic Testing Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  3. Global Genetic Testing Market, By Test Type, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • New-born Screening
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Diagnostic Testing
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Prenatal Testing
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Carrier Testing
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Predictive and Pre-symptomatic Testing
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Genetic Testing Market Forecast, By Technology, 2015 – 2019 and Forecast, 2020 – 2026
    • Molecular Testing
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Cytogenetic Testing
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Biochemical Testing
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Genetic Testing Market Forecast, By Application, 2015 – 2019 and Forecast, 2020 – 2026
    • Thalassemia
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Sickle Cell Anemia
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Cancer
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Cystic Fibrosis
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
    • Alzheimer’s Disease
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Huntington’s Disease
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Genetic Testing Market Forecast, By End User, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Hospitals
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Clinics
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Diagnostic Centers
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Genetic Testing Market Forecast, By Region, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Genetic Testing Market – Opportunity Analysis Index, By Test Type, Technology, Application, End User, and Region, 2020 – 2026
  2. North America Genetic Testing Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Test Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • New-born Screening
      • Diagnostic Testing
      • Prenatal Testing
      • Carrier Testing
      • Predictive and Pre-Symptomatic Testing
    • Technology Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Molecular Testing
      • Cytogenetic Testing
      • Biochemical Testing
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Thalassemia
      • Sickle Cell Anemia
      • Cancer
      • Cystic Fibrosis
      • Alzheimer’s Disease
      • Huntington’s Disease
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • US.
      • Canada
    • North America Genetic Testing Market – Opportunity Analysis Index, By Test Type, Technology, Application, End User, and Country, 2020 – 2026
    • North America Genetic Testing Market Dynamics – Trends
  3. Europe Genetic Testing Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Test Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • New-born Screening
      • Diagnostic Testing
      • Prenatal Testing
      • Carrier Testing
      • Predictive and Pre-Symptomatic Testing
    • Technology Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Molecular Testing
      • Cytogenetic Testing
      • Biochemical Testing
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Thalassemia
      • Sickle Cell Anemia
      • Cancer
      • Cystic Fibrosis
      • Alzheimer’s Disease
      • Huntington’s Disease
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Genetic Testing Market – Opportunity Analysis Index, By Test Type, Technology, Application, End User, and Country, 2020 – 2026
    • Europe Genetic Testing Market Dynamics – Trends
  4. Asia-Pacific Genetic Testing Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Test Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • New-born Screening
      • Diagnostic Testing
      • Prenatal Testing
      • Carrier Testing
      • Predictive and Pre-Symptomatic Testing
    • Technology Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Molecular Testing
      • Cytogenetic Testing
      • Biochemical Testing
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Thalassemia
      • Sickle Cell Anemia
      • Cancer
      • Cystic Fibrosis
      • Alzheimer’s Disease
      • Huntington’s Disease
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Genetic Testing Market – Opportunity Analysis Index, By Test Type, Technology, Application, End User, and Country, 2020 – 2026
    • Asia-Pacific Genetic Testing Market Dynamics – Trends
  5. Latin America Genetic Testing Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Test Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • New-born Screening
      • Diagnostic Testing
      • Prenatal Testing
      • Carrier Testing
      • Predictive and Pre-Symptomatic Testing
    • Technology Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Molecular Testing
      • Cytogenetic Testing
      • Biochemical Testing
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Thalassemia
      • Sickle Cell Anemia
      • Cancer
      • Cystic Fibrosis
      • Alzheimer’s Disease
      • Huntington’s Disease
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Genetic Testing Market – Opportunity Analysis Index, By Test Type, Technology, Application, End User, and Country, 2020 – 2026
    • Latin America Genetic Testing Market Dynamics – Trends
  6. Middle East and Africa Genetic Testing Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Test Type Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • New-born Screening
      • Diagnostic Testing
      • Prenatal Testing
      • Carrier Testing
      • Predictive and Pre-Symptomatic Testing
    • Technology Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Molecular Testing
      • Cytogenetic Testing
      • Biochemical Testing
    • Application Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Thalassemia
      • Sickle Cell Anemia
      • Cancer
      • Cystic Fibrosis
      • Alzheimer’s Disease
      • Huntington’s Disease
      • Others
    • End User Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospitals
      • Clinics
      • Diagnostic Centers
    • Country Analysis 2015 – 2019 and Forecast 2020 – 2026 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Genetic Testing Market – Opportunity Analysis Index, By Test Type, Technology, Application, End User, and Country, 2020 – 2026
    • MEA Genetic Testing Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Test Type & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Qiagen N.V. (Germany)
      • PerkinElmer, Inc. (U.S.)
      • Applied Biosystems (U.S.)
      • Biocartis S.A. (Switzerland)
      • Genentech, Inc. (U.S.)
      • Hoffmann La Roche Ltd. (Switzerland)
      • Quest Diagnostics (U.S.)
      • Illumina, Inc. (U.S.)
      • Bayer Diagnostics (Germany)
      • Konica Minolta, Inc. (Japan)
      • Abbott Laboratories (U.S.)
      • Myriad Genetics (U.S.)
    1. Research Methodology
    2. Key Assumptions and Acronyms

Report

Company Profile

  • Qiagen N.V.
  • PerkinElmer, Inc.
  • Applied Biosystems
  • Biocartis S.A.
  • Genentech, Inc.
  • Hoffmann La Roche Ltd.
  • Quest Diagnostics
  • Illumina, Inc.
  • Bayer Diagnostics
  • Konica Minolta, Inc.
  • Abbott Laboratories
  • Myriad Genetics

Description

Global Genetic Testing Market was valued at USD 13.6 Billion in 2020 and is anticipated to grow at USD 29.88 Billion till 2027 recording a CAGR of 11.9% during the forecast period 2021-2027. The DNA, a chemical databank that conveys commands for the body’s utilities, is examined during genetic testing. Changes or mutations in the genes that may cause illness or disease can be discovered by genetic testing. The rise in the incidence of genetic diseases and the growing demand for identifying genetic disorders are two major factors driving growth in the global genetic testing market. Chronic diseases are primarily caused by genetic abnormalities. Genetic testing makes available technology that aid in the early discovery of various genetic illnesses, as well as treatment and prevention. Genetic testing is widely utilised for a variety of applications. In 2015, there were around 15.1 million new cancer cases worldwide, with more than half of these instances coming from economically developing countries such as India, China, and others. Prenatal genetic testing is a procedure that aids in the detection of genetic diseases in the foetus. Mutations in a person’s genes or chromosomes are the most common cause of genetic disorders. Aneuploidy, trisomy, monosomy, and a variety of other hereditary illnesses are among the most common genetic abnormalities. Pharmacogenomics is the study of congenital changes in human genes that influence a person’s pharmacological response. Pharmacogenomics is a field that combines pharmaceutical and genetic sciences. As a result, it is the science of customising a medicine depending on a person’s genetic composition. A predisposition is an increase in the likelihood of a disease developing as a result of a person’s genetic composition. A genetic predisposition is caused by specific genetic abnormalities that are passed down from one parent to the next. Global genetic testing market report gives comprehensive outlook on genetic testing across the globe with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX